COVID-19 and Thrombosis in Cancer Patients: The Clot Thickens
March 2021 marks a full year since the WHO officially declared the coronavirus disease 2019 (COVID-19) outbreak a...
Most Read
Lessons from the CATCH study: beware of the risk of bleeding in neoplastic patients treated for VTE
The results of an interesting secondary analysis of the CATCH study were published recently and they are useful for a...
Arterial thromboembolism can also be the first clinical manifestation of a neoplasm
Several studies showed that venous thrombosis can be the first clinical manifestation of an occult neoplasm. For this...
Trial updates In thromboprophylaxis of cancer-related venous thromboembolism
The past decade has seen a large number of studies focusing on identifying cancer patients at high risk for venous...
American Society of Hematology Guidelines for Management of Cancer-Associated Thrombosis
Introduction The risk of venous thromboembolism (VTE) is substantially increased in patients with cancer especially...
Risk of thromboembolism in cancer patients with Port-a-Cath. Results and implications of the ONCOCIP study
The normal experience of cancer patients who receive an implantable venous access device (Port-a-Cath) for chemotherapy...
The role of microparticles in VTE
Cancer-associated venous thromboembolism (VTE) causes significant morbidity and mortality in patients and constitutes...
ISTH 2019: The CAT treatment, from trials to clinical practice
Straight from ISTH 2019 Alok Khorana tells us what’s new in the CAT...
Update on Oncology & Thrombosis to include COVID‐19. Your questions answered by our speakers
During our webinar “Update on Oncology & Thrombosis to include COVID‐19”, the interest from the audience was...